Inventor
ERIC KRAULAND
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
G01NInvestigating or analysing materials by determining their chemical or physical properties21%
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes10%
C40BCombinatorial chemistry7%
C12YEnzymes3%
PatentTitleYear
12,258,679Polyclonal mixtures of antibodies, and methods of making and using them202512,187,799Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor202512,134,648Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor202411,746,160Antibodies against BACE1 and use thereof for neural disease immunotherapy202311,542,330Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use202311,485,795Anti-PCSK9 antibody and use thereof202211,390,964Polyclonal mixtures of antibodies, and methods of making and using them2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ADIMAB LLC (4)· patent assignee history
2022Patents assigned to INNOVENT BIOLOGICS SUZHOU CO LTD (1)· patent assignee history
2022–2025Based in US· patent location history
2022Based in CN· patent location history
2023Patents assigned to GENENTECH INC (1)· patent assignee history
2024–2025Patents assigned to UNIV TEXAS (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ADIMAB LLC | 4 | 2022–2025 |
| UNIV TEXAS | 2 | 2024–2025 |
| GENENTECH INC | 1 | 2023 |
| INNOVENT BIOLOGICS SUZHOU CO LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |
| CN | 1 | 2022 |